MYOS RENS is evaluating the genotypic characteristics and molecular pathways that contribute to the changes seen in muscle and inflammatory disease states associated with sarcopenia and related disorders.
MYOS RENS takes its responsibility to the environment and the community very seriously. MYOS RENS is committed to being a good corporate citizen and welcomes suggestions on enhancing our contributions in this regard.
Conference Call & Webcast: Wednesday, March 28, 2018 at 11:00 am ET
CEDAR KNOLLS, N.J., March 20, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and owner of Fortetropin®, the natural food product that helps build lean muscle in conjunction with resistance training, announced [...]
Attendees of the Arnold Fitness EXPO can Sample Qurr® Powders, Puddings and Shakes, and Purchase Products with a Special Expo Discount at Booth #513.
CEDAR KNOLLS, N.J., Feb. 15, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and owner of Fortetropin®, the fertilized egg [...]